Immunocore Ownership | Who Owns Immunocore?
Immunocore Ownership Summary
Immunocore is owned by 25.52% institutional investors, 0.03% insiders, and 74.45% retail investors. T. rowe price investment management is the largest institutional shareholder, holding 14.05% of IMCR shares. Vanguard Health Care Inv is the top mutual fund, with 7.22% of its assets in Immunocore shares.
IMCR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immunocore | 25.52% | 0.03% | 74.45% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| T. rowe price investment management | 7.06M | 14.05% | $256.63M |
| Rtw investments, lp | 4.87M | 9.68% | $176.92M |
| Wellington management group llp | 4.78M | 9.51% | $173.69M |
| Fmr | 4.42M | 8.79% | $160.59M |
| Primecap management co/ca/ | 3.96M | 7.86% | $137.52M |
| Bellevue group | 2.80M | 5.56% | $101.61M |
| Baker bros. advisors lp | 2.32M | 4.62% | $84.38M |
| Tang capital management | 2.31M | 4.58% | $83.76M |
| Deep track capital, lp | 1.80M | 3.58% | $65.39M |
| Bvf inc/il | 1.57M | 3.13% | $57.19M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tang capital management | 2.31M | 3.22% | $83.76M |
| Logos global management lp | 850.00K | 2.77% | $30.88M |
| Kynam capital management, lp | 1.01M | 2.73% | $36.67M |
| Bvf inc/il | 1.57M | 2.32% | $57.19M |
| Rtw investments, lp | 4.87M | 2.18% | $176.92M |
| Bellevue group | 2.80M | 2.11% | $101.61M |
| Deep track capital, lp | 1.80M | 1.82% | $65.39M |
| Diadema partners lp | 124.38K | 1.16% | $4.52M |
| Eschler asset management llp | 40.00K | 1.08% | $1.45M |
| Persistent asset partners | 28.61K | 0.71% | $1.04M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wellington management group llp | 4.78M | 0.03% | 567.31K |
| Bvf inc/il | 1.57M | 2.32% | 550.00K |
| Bellevue group | 2.80M | 2.11% | 354.97K |
| Caption management | 463.66K | 0.13% | 284.16K |
| Loomis sayles & co l p | 301.81K | 0.01% | 282.82K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | - | - | -1.79M |
| General atlantic | - | - | -1.26M |
| Braidwell lp | - | - | -797.27K |
| Pictet asset management sa | - | - | -706.61K |
| Bill & melinda gates foundation | - | - | -576.92K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Axa investment managers | 95.17K | 0.01% | 95.17K | $3.46M |
| Lazard asset management | 88.89K | 0.00% | 88.89K | $2.79M |
| Hussman strategic advisors | 42.00K | 0.35% | 42.00K | $1.46M |
| Public employees retirement system of ohio | 25.16K | 0.00% | 25.16K | $914.17K |
| Schonfeld strategic advisors | 19.92K | 0.00% | 19.92K | $723.77K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -6.00 |
| Ronald blue trust | -6.00 |
| Northwestern mutual wealth management | -7.00 |
| Geneos wealth management | -11.00 |
| Raymond james financial | -22.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 97 | -32.64% | 12,862,798 | -74.16% | 25 | 0.26% | 49 | -19.67% | 24 | -48.94% |
| Sep 30, 2025 | 136 | -1.45% | 49,176,961 | 2.73% | 97 | 1.08% | 60 | -16.67% | 43 | 7.50% |
| Jun 30, 2025 | 141 | 11.90% | 48,351,355 | 0.95% | 96 | 1.05% | 74 | 23.33% | 40 | 25.00% |
| Mar 31, 2025 | 125 | 2.46% | 47,879,396 | 4.09% | 95 | 1.13% | 61 | 24.49% | 31 | -31.11% |
| Dec 31, 2024 | 76 | -45.71% | 20,547,400 | -54.62% | 41 | 0.50% | 28 | -57.58% | 28 | -26.32% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 3.66M | 7.22% | - |
| Vanguard Capital Opportunity Inv | 2.53M | 4.99% | 89.79K |
| T. Rowe Price US Small-Cap Core Equity | 2.09M | 4.12% | -70.50K |
| T. Rowe Price Small-Cap Stock | 2.09M | 4.12% | -115.60K |
| Fidelity Growth Compy Commingled Pl S | 1.65M | 3.26% | 60.51K |
| BB Biotech AG Ord | 1.21M | 2.41% | - |
| PRIMECAP Odyssey Aggressive Growth | 1.22M | 2.40% | 102.11K |
| T. Rowe Price Instl Small-Cap Stock | 1.17M | 2.30% | -24.02K |
| Fidelity Growth Compy Commingled Pl O | 1.15M | 2.30% | 101.00 |
| Fidelity Growth Company Fund | 1.15M | 2.27% | 34.44K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 18, 2026 | Jallal Bahija | CHIEF EXECUTIVE OFFICER | Sell | $371.18K |
| Feb 18, 2026 | GOLL JOHN | SVP, FINANCE & CAO | Sell | $22.58K |
| Feb 18, 2026 | St Leger Tina Amber | CHIEF HR OFFICER | Sell | $32.35K |
| Feb 18, 2026 | Berman David M | HEAD OF R&D | Sell | $192.97K |
| Dec 04, 2025 | Berman David M | HEAD OF R&D | Sell | $1.26M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 4 |
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | 7 |
| 2025 Q2 | - | - |
| 2025 Q1 | 4 | 1 |
IMCR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools